7N44
Crystal structure of the SARS-CoV-2 (2019-NCoV) main protease in complex with 5-(3-{3-chloro-5-[(5-methyl-1,3-thiazol-4-yl)methoxy]phenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1H,3H)-dione (compound 13)
Summary for 7N44
Entry DOI | 10.2210/pdb7n44/pdb |
Descriptor | 3C-like proteinase, 5-(3-{3-chloro-5-[(5-methyl-1,3-thiazol-4-yl)methoxy]phenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1H,3H)-dione (3 entities in total) |
Functional Keywords | novel coronavirus, antiviral, drug design, viral protein, hydrolase |
Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2) |
Total number of polymer chains | 1 |
Total formula weight | 34345.51 |
Authors | Reilly, R.A.,Zhang, C.H.,Deshmukh, M.G.,Ippolito, J.A.,Hollander, K.,Jorgensen, W.L.,Anderson, K.S. (deposition date: 2021-06-03, release date: 2021-07-21, Last modification date: 2023-10-18) |
Primary citation | Zhang, C.H.,Spasov, K.A.,Reilly, R.A.,Hollander, K.,Stone, E.A.,Ippolito, J.A.,Liosi, M.E.,Deshmukh, M.G.,Tirado-Rives, J.,Zhang, S.,Liang, Z.,Miller, S.J.,Isaacs, F.,Lindenbach, B.D.,Anderson, K.S.,Jorgensen, W.L. Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency. Acs Med.Chem.Lett., 12:1325-1332, 2021 Cited by PubMed: 34408808DOI: 10.1021/acsmedchemlett.1c00326 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.94 Å) |
Structure validation
Download full validation report